Next Pharma Sourcing S.a.s. Pharmaceutical Import Profile — Colombia (DGFT 2022–2026)

Name: Next Pharma Sourcing S.a.s. Pharmaceutical Import Records from India — 3 Products, $3.1M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Next Pharma Sourcing S.a.s. — Pharmaceutical Importer Profile (2026) | 3 Products, $3.1M Trade | TransData Nexus

Next Pharma Sourcing S.a.s.

Pharmaceutical Importer · Colombia · Cardiovascular Focus · $3.1M Total Trade · DGFT Verified

Next Pharma Sourcing S.a.s. is a pharmaceutical importer based in Colombia with a total trade value of $3.1M across 3 products in 3 therapeutic categories. Based on 63 verified import shipments from Indian Customs (DGFT) records, the company actively imports across multiple product segments. Next Pharma Sourcing S.a.s. sources from 3 verified Indian suppliers, with Rpg Life Sciences Limited accounting for 84.7% of imports.

Next Pharma Sourcing S.a.s. — Import Portfolio & Supplier Network

Next Pharma Sourcing S.a.s. import network — 3 products from Indian suppliers. Source: Indian Customs (DGFT).

Who Are the Verified Indian Suppliers to Next Pharma Sourcing S.a.s.?

Customs-verified supplier relationships from Indian DGFT records

Supplier	Value	Shipments	Share
Rpg Life Sciences Limited	$1.0M	53	84.7%
Gland Pharma Limited	$150.0K	3	12.2%
Kwality Pharmaceuticals Limited

What Formulations Does Next Pharma Sourcing S.a.s. Import?

Formulation	Value	Ships
Azathioprine TAB 50MG 100's nps	$288.8K	6
Prevlog tablets (10x10?s) (alfaren	$200.0K	4
Heparin sodium INJ 25000iu/5ML	$100.0K	2
Heparin sodium INJ 25000iu/5ML(5000iu/ML	$50.0K	1
Prevlog tablets (alfaren ketoanalogues tablets) (10x10s) (4124 boxes)	$50.0K	1
Prevlog tablets (10x10s)(alfaren ketoanalogues tablets) (Pack size: 4224 boxes x 10 x 10=422400 tablets)	$50.0K	1
Prevlog tablets (10x10s)(alfaren ketoanalogues tablets) (Pack size:4224 boxes x 10 x 10=422400 tablets)	$48.9K	1
Prevlog tablets (10x10s)(alfaren ketoanalogues tablets) (Pack size: 4203 boxes x 10 x 10=420300 tablets)	$48.6K	1
Prevlog tablets (10x10s)(alfaren ketoanalogues tablets) (Pack size:4187 boxes x 10 x 10=418700 tablets)	$48.3K	1
Azathioprine TAB 50MG 100s nps	$46.4K	1
Alfaren ketoanalogues tablets (prevlog tablets) (10x10s) (2967 boxes x 10x10s= 296700 nos	$41.3K	1
Remifentanil hydrochloride for injection2mg (batch no & other details as per inv & packing list)	$39.2K	1
Prevlog tablets (10x10s) (alfaren ketoanalogues tablets) (3178 boxes of 10x10s )	$39.1K	1
Prevlog tablets (10x10s)(alfaren ketoanalogues tablets) (Pack size:3151 boxes x 10 x 10 =315100 tablets)	$39.0K	1
Prevlog tablets (10x10s) (alfaren ketoanalogues tablets) (3095 boxes of 10x10s)	$35.9K	1

Next Pharma Sourcing S.a.s. imports 40 distinct pharmaceutical formulations. Showing top 15 by value. For full formulation-level data, contact TransData Nexus.

Import Portfolio — Top 3 by Import Value

#	Product	Category	Value	Ships	Share	Rk
1	Heparin	Cardiovascular	$1.9M	38	0.5%	17
2	Immunoglobulin	Other	$800.0K	16	0.4%	7
3	Azathioprine	Immunosuppressants	$450.0K	9	1.3%	11

Next Pharma Sourcing S.a.s. imports 3 pharmaceutical products across 3 categories into Colombia totaling $3.1M.

Next Pharma Sourcing S.a.s. — Corporate Profile & Information

Company type, headquarters, distribution network, and industry role

1Company Overview

Next Pharma Sourcing S.A.S. is a Colombian pharmaceutical company specializing in the wholesale distribution of medicinal products, including pharmaceuticals, cosmetics, and personal care items. Established on September 15, 2010, the company operates as a Sociedad por Acciones Simplificada (S.A.S.), a simplified joint-stock company structure prevalent in Colombia. Headquartered in Bogotá, the capital city, Next Pharma Sourcing S.A.S. plays a pivotal role in the Colombian pharmaceutical supply chain by sourcing and distributing a diverse range of medical products to meet the country's healthcare needs.

2Distribution Network

While specific details about Next Pharma Sourcing S.A.S.'s warehouse locations and logistics capabilities are not publicly disclosed, the company's strategic position in Bogotá suggests a centralized distribution model. Bogotá's status as Colombia's primary commercial hub provides advantageous access to national and international transportation networks, facilitating efficient distribution across the country. The company's operations likely leverage these logistical advantages to ensure timely and reliable delivery of pharmaceutical products to various regions within Colombia.

3Industry Role

Next Pharma Sourcing S.A.S. functions as a primary wholesaler in Colombia's pharmaceutical supply chain. By importing and distributing a wide array of medicinal products, the company serves as a critical intermediary between international manufacturers and local healthcare providers. This role ensures the availability of essential medications and medical supplies throughout Colombia, contributing to the overall efficiency and effectiveness of the nation's healthcare system.

TransData Nexus Research · Company registries, industry databasesMar 2026

Supplier Relationship Intelligence — Next Pharma Sourcing S.a.s.

Sourcing concentration, supply chain resilience, and strategic implications

1Sourcing Concentration Analysis

Next Pharma Sourcing S.A.S. demonstrates a high degree of supplier concentration, with 84.7% of its imports sourced from RPG Life Sciences Limited, a single supplier. This significant reliance indicates a strategic partnership, potentially offering benefits such as favorable pricing, consistent product quality, and streamlined logistics. However, such dependency also introduces risks, including supply chain disruptions in the event of issues with the primary supplier. The company's limited diversification in sourcing may expose it to vulnerabilities, especially if RPG Life Sciences Limited faces operational challenges or regulatory hurdles.

2Supply Chain Resilience

The resilience of Next Pharma Sourcing S.A.S.'s supply chain is closely tied to its reliance on RPG Life Sciences Limited. The absence of additional suppliers suggests a lack of contingency options, which could be problematic if the primary supplier encounters disruptions. The company's import portfolio comprises 40 unique formulations, indicating a degree of product diversification. However, the heavy reliance on a single supplier for these formulations may limit the company's ability to adapt to sudden changes in supply availability. To enhance supply chain resilience, it would be prudent for Next Pharma Sourcing S.A.S. to consider diversifying its supplier base and establishing relationships with multiple manufacturers.

Importing Pharmaceuticals into Colombia — Regulatory Framework

Regulatory authority, GMP requirements, import licensing for Colombia

1Regulatory Authority & Framework

In Colombia, the National Food and Drug Surveillance Institute (INVIMA) is the primary regulatory authority overseeing the importation, distribution, and commercialization of pharmaceutical products. INVIMA ensures that all medical products meet the required safety, efficacy, and quality standards before they enter the Colombian market. The regulatory framework governing pharmaceutical imports includes compliance with Good Manufacturing Practices (GMP), product registration, and adherence to labeling and packaging requirements. Indian pharmaceutical exporters must navigate this regulatory landscape to successfully enter the Colombian market.

2Import Licensing & GMP

Import licensing in Colombia requires that pharmaceutical products be registered with INVIMA, which involves submitting detailed documentation about the product's composition, manufacturing process, and clinical data. Additionally, products must be manufactured in facilities that comply with GMP standards recognized by INVIMA. Colombia acknowledges GMP certifications from reputable international bodies, including the World Health Organization (WHO) and the European Union (EU). Indian exporters seeking to supply Next Pharma Sourcing S.A.S. must ensure that their manufacturing facilities hold valid GMP certifications from these recognized authorities.

Next Pharma Sourcing S.a.s. — Procurement Pattern Analysis

Product strategy, sourcing profile, and market positioning

1Product Strategy

Next Pharma Sourcing S.A.S. focuses on importing products in the cardiovascular, immunosuppressant, and other therapeutic categories. The substantial import value in the cardiovascular category (60.3%) suggests a strategic emphasis on addressing prevalent health conditions such as hypertension and heart disease in Colombia. The inclusion of immunosuppressants (14.3%) indicates a commitment to providing treatments for autoimmune disorders and transplant patients. The 'Other' category (25.4%) reflects a diversified approach to meet various medical needs. This product strategy aligns with the healthcare demands of the Colombian population, focusing on critical and chronic health conditions.

2Sourcing Profile

Next Pharma Sourcing S.A.S. primarily sources generic pharmaceutical products, as evidenced by its import portfolio consisting of finished pharmaceutical formulations such as tablets, capsules, syrups, and injections. The company's sourcing strategy emphasizes cost-effective solutions to meet the diverse therapeutic needs of the Colombian market. India's robust pharmaceutical manufacturing sector, known for producing high-quality generics, aligns well with Next Pharma Sourcing S.A.S.'s procurement objectives.

3Market Positioning

Seller's Guide — How to Become a Supplier to Next Pharma Sourcing S.a.s.

Opportunity assessment, qualifications, and practical approach strategy

1Opportunity Assessment

There is a realistic opportunity for new Indian suppliers to enter the Colombian market through Next Pharma Sourcing S.A.S. The company's existing reliance on a single supplier indicates potential for diversification, which could enhance supply chain resilience and reduce dependency risks. Indian exporters can explore this opportunity by offering high-quality generic products that meet INVIMA's regulatory standards and align with the therapeutic categories prioritized by Next Pharma Sourcing S.A.S.

2Requirements & Qualifications

Indian exporters aiming to supply Next Pharma Sourcing S.A.S. must ensure that their products are registered with INVIMA and manufactured in facilities that comply with GMP standards recognized by INVIMA. Products must undergo batch testing and stability studies to meet Colombian quality standards. Labeling must be in Spanish and include all required information, and serialization is mandatory. Additionally, exporters should be prepared to navigate the regulatory processes and maintain compliance with INVIMA's requirements to facilitate successful market entry.

3How to Approach

Frequently Asked Questions — Next Pharma Sourcing S.a.s.

What products does Next Pharma Sourcing S.a.s. import from India?

Next Pharma Sourcing S.a.s. imports 3 pharmaceutical products across 3 categories. Top imports: Heparin ($1.9M), Immunoglobulin ($800.0K), Azathioprine ($450.0K).

Who supplies pharmaceuticals to Next Pharma Sourcing S.a.s. from India?

Next Pharma Sourcing S.a.s. sources from 3 verified Indian suppliers. The primary supplier is Rpg Life Sciences Limited (84.7% of imports, $1.0M).

What is Next Pharma Sourcing S.a.s.'s total pharmaceutical import value?

Next Pharma Sourcing S.a.s.'s total pharmaceutical import value from India is $3.1M, based on 63 verified shipments in Indian Customs (DGFT) data.

What therapeutic categories does Next Pharma Sourcing S.a.s. focus on?

Next Pharma Sourcing S.a.s. imports across 3 categories. The largest: Cardiovascular (60.3%), Other (25.4%), Immunosuppressants (14.3%).

Get Full Next Pharma Sourcing S.a.s. Import Intelligence

Access shipment-level details, supplier connections, pricing data, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify import regulations and drug registration requirements with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Profile aggregates 3 company name variants from customs records. For current shipment-level data, contact TransData Nexus.